title: Anti-androgen treatment of prostatic carcinoma may be a risk factor for development of rheumatoid arthritis.
authors.affiliation: Department of Medicine, University of Western Ontario, London, Canada. janet.pope@sjhc.london.on.ca
authors.forename: Janet E
authors.initials: JE
authors.lastname: Pope
authors.forename: Mala
authors.initials: M
authors.lastname: Joneja
authors.forename: Paul
authors.initials: P
authors.lastname: Hong
mesh_terms: D000368:Aged; D000726:Androgen Antagonists / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D012307:Risk Factors; D013739:Testosterone / Q000097:blood
chemical_list: D000726:Androgen Antagonists; D013739:Testosterone; D017430:Prostate-Specific Antigen